Low Leukocyte MGMT Accompanies Temozolomide-Induced Myelotoxicity in Brain Tumor Patients . J. Can. Res. Updates 2012, 1 (1),  44-48. https://doi.org/10.6000/1929-2279.2012.01.01.08.